Vubotics Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Vubotics current Real Value cannot be determined due to lack of data. The regular price of Vubotics is $0.0. Our model measures the value of Vubotics from inspecting the company fundamentals such as Return On Asset of -1.8, ebitda of (2.59 M), and Price To Sales of 24,940 X as well as reviewing its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Vubotics' price fluctuation is out of control at this time. Calculation of the real value of Vubotics is based on 3 months time horizon. Increasing Vubotics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Vubotics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Vubotics Stock. However, Vubotics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0 | Real 0.0 | Hype 0.0 |
The real value of Vubotics Stock, also known as its intrinsic value, is the underlying worth of Vubotics Company, which is reflected in its stock price. It is based on Vubotics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Vubotics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Vubotics helps investors to forecast how Vubotics stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Vubotics more accurately as focusing exclusively on Vubotics' fundamentals will not take into account other important factors: Vubotics Total Value Analysis
Vubotics is at this time anticipated to have valuation of 306.09 K with market capitalization of 630.29 M, debt of 400 K, and cash on hands of 592.21 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Vubotics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
306.09 K | 630.29 M | 400 K | 592.21 K |
Vubotics Investor Information
The company had not issued any dividends in recent years. Vubotics had 1:4 split on the 19th of August 1998. Based on the key indicators related to Vubotics' liquidity, profitability, solvency, and operating efficiency, Vubotics is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Vubotics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Vubotics has an asset utilization ratio of 6.8 percent. This indicates that the Company is making $0.068 for each dollar of assets. An increasing asset utilization means that Vubotics is more efficient with each dollar of assets it utilizes for everyday operations.Vubotics Profitability Analysis
The company reported the previous year's revenue of 37 K. Net Loss for the year was (2.65 M) with profit before overhead, payroll, taxes, and interest of 25.27 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Vubotics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Vubotics and how it compares across the competition.
About Vubotics Valuation
The delisted stock valuation mechanism determines Vubotics' current worth on a weekly basis. Our valuation model uses a comparative analysis of Vubotics. We calculate exposure to Vubotics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Vubotics's related companies.VuBotics, Inc. develops VuIT software application that allows digital readers to increase their reading speed and comprehension in the United States. The company was founded in 1981 and is based in Atlanta, Georgia. Vubotics is traded on OTC Exchange in the United States.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Vubotics Stock
If you are still planning to invest in Vubotics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vubotics' history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |